Wall Street analysts highlight Meta, UnitedHealth, and Marvell

Wall Street analysts have identified growth potential for Meta Platforms, UnitedHealth, and Marvell Technology, despite global market pressures related to artificial intelligence and oil prices.

Meta Platforms is seeing momentum following the launch of its AI agent, Muse, which reportedly reached 1.3 million daily active users within five weeks. Guggenheim analyst Michael Morris maintained a buy recommendation and raised the price target from $700 to $850, anticipating monetization through business-to-consumer advertising via AI agents.

UnitedHealth reported third-quarter 2026 results that exceeded expectations, leading the company to raise its full-year profit projections. Morgan Stanley analyst Erin Wright reiterated a buy recommendation with a $529 price target, noting that strong performance in the UnitedHealthcare and Optum Health divisions supported an adjusted earnings per share forecast of at least $20.50 for 2026.